KEELIN EVANS: Open Payments
NPI 1134953276 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$211 in 13 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $54 · 2025 $211
Food & beverage: $211
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| Ardelyx, Inc. | 3 | $48 |
| Madrigal Pharmaceuticals | 3 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
| Novo Nordisk Inc | 1 | $21 |
Products named: XIFAXAN, IBSRELA, REZDIFFRA, DUPIXENT, Wegovy.
Industry payments across PA — which companies pay providers there.
